Skip to content
The Nexus
BUSINESSApr 13 · 14:09 UTCBLOOMBERGAnthony Hughes

Life Science Firms Seek $693 Million in US IPOs as Pace Picks Up

Life science companies are pursuing $693 million in U.S. IPOs, indicating growing investor interest in the sector. The New York Stock Exchange is highlighted as a key market for these offerings.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
New York Stock ExchangeorganizationLife Science Firmstopic
Spot something wrong with this article?Report a problem →
Forward this